Results per Page:
Post-translational modification of an essential viral protein regulates early infection
From the Avgousti Lab, Human Biology Division
Vaccine targets that accommodate evolving SARS-CoV-2 variants
From the Overbaugh Lab, Human Biology and Public Health Sciences Divisions
Mapping a pathway to hope
How Fred Hutch researchers revealed the biology behind a drug’s success in a rare liver cancer and paired it with another drug for a one-two punch
A subtype of bacteria linked to colorectal cancer
From the Bullman Lab, Human Biology Division and Johnston Lab, Vaccine and Infectious Disease Division
When a single amino acid makes all the difference
From the Geballe Lab, Human Biology Division
Un nuevo tipo de célula vinculada con el cáncer gástrico hace su debut
Del laboratorio Salama, División de Biología Humana
Exit or not? HSV-1 infection redistributes heterochromatin to exit the nucleus
From the Avgousti lab, Human Biology Division
Interrogating heterogeneous PSMA expression in advanced prostate cancer
From the Haffner Lab, Human Biology Division
A chink in lung cancer’s armor
From the Berger Lab, Human Biology Division
New technique reveals cells’ tiny engines unexpectedly shrug off DNA damage from toxic chemicals
A precise new technique reveals that our cells’ engines, mitochondria, unexpectedly shrug off DNA damage from toxic chemicals
‘We have to be daring’: A doctor’s quest to unlock answers about prostate cancer
New study by Dr. Andrew Hsieh identifies a mode of drug resistance to emerging treatments